Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755416 · ClinicalTrials.gov registry record · Phase 2
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
A Phase 2 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT01755416 is a Phase 2 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 18 participants.
The verdict
NCT01755416, a Phase 2 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
Hypothesis: In type 1 diabetes mellitus, in the setting of a closed loop glucose control system: adjunctive therapy with Liraglutide will afford better post-prandial glycemic excursions than insulin mono-therapy. Specific Aim: To determine if post-prandial glucose excursions are lowered with the addition of Liraglutide compared to insulin mono-therapy. Study Design: This is a randomized open labeled crossover design trial comparing adjuvant Liraglutide and insulin Vs. insulin mono-therapy using the ePID closed-loop system for insulin delivery.
Interventions
- DRUG Closed loop with sensor and Insulin
- DRUG Closed loop with sensor, Insulin and Liraglutide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01755416
The ClinicalTrials.gov registry entry for NCT01755416 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Closed loop with sensor and Insulin is the first listed.
NCT01755416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01755416 about?
NCT01755416 is a clinical study titled "Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting". Hypothesis: In type 1 diabetes mellitus, in the setting of a closed loop glucose control system: adjunctive therapy with Liraglutide will afford better post-prandial glycemic excursions than insulin mono-therapy. Specific Aim: To determine if post-prandial glucose excursions are lowered with the ad...
What is the current status of trial NCT01755416?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2013-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01755416?
The interventions under investigation include: Closed loop with sensor and Insulin (DRUG), Closed loop with sensor, Insulin and Liraglutide (DRUG).
Who is sponsoring clinical trial NCT01755416?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.